American healthcare firm Bon Secours Mercy Health (BSMH) has expressed its intent to expand its existing Global Business ...

A study published in July 2025 issue of Journal of Neurology explored how genetic variability in the FCGR2/3 locus, which ...

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

While it is not a common condition, Guillain-Barré Syndrome (GBS) is garnering increased interest from the broader medical diagnostics industry as new cases are reported worldwide each year and linked ...

MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained ...

Medical education minister Hasan Mushrif asked the administration to effectively implement the SOP to prevent the outbreak of the GBS virus. Also, the daily updated information on GBS patients ...

GBS will be working with: Sutter Health, Mills-Peninsula Medical Center to enroll approximately 40 adult subjects diagnosed with type 2 diabetes in the study.

BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the ...

Bacteria which 1 in 10 pregnant women carry, and which can cause death or serious complications in their babies, could be targeted in a cost-effective way by a future vaccine – even if it costs ...

Medical officers and healthcare staff should be well-informed to detect and refer suspected/probable cases of GBS to the nearest tertiary care health facility immediately ensuring timely treatment.